Gynecologic Oncologist @osuccc_james
columbus ohio
Joined February 2013
- Tweets1.2K
- Following2.2K
- Followers1.2K
- Likes2.2K
Casey Cosgrove retweeted
6/
My take on this is that Pembro alone is a reasonable option for patients who can’t or won’t receive chemo. It should not be the new standard. For most patients, ICI + CP remains SOC.
Casey Cosgrove retweeted
🚨Work from Drs. Alessandro Canella, @CaseCos & team being presented at #SITC2025: “DKK1 expression & immune cell infiltration in MMRd #EndometrialCancer.” #OhioStateGynOnc @OhioStatePIIO @OSUCCC_James #ImmunoOncology
Casey Cosgrove retweeted
Starting the day with #ASCO25 Review at @OhioStateMedOnc with an stellar lineup of speakers with our chairs @AsrarAlahmadi & @AshishManne a great opportunity for an update and networking with our colleagues from Ohio!
@LoganRoofMD
@lingbin_meng
@HasanovLab @OSUCCC_James
Casey Cosgrove retweeted
Join Ohio State experts to learn about the latest in oncology innovation at our 2025 ASCO review, 7/12 in Columbus. Click for info/registration: go.osu.edu/C6qH
Casey Cosgrove retweeted
Meet the talented team of endometrial cancer experts at the @OSUCCC_James. I’m proud to call them all colleagues, and honored to work alongside them to care for gynecologic cancer patients @OhioState. cancer.osu.edu/for-patients-…
Casey Cosgrove retweeted
The FSU family is deeply saddened by the passing of Florida State University alumnus and retired chemistry Professor Robert Holton. Dr. Holton’s groundbreaking synthesis of Taxol made the cancer drug widely available worldwide. His work saved countless lives and continues to inspire generations of scientists. news.fsu.edu/news/science-te…
Casey Cosgrove retweeted
Unfortunately the incidence of endometrial/uterine cancer is still going up.
News: Annual Report to the Nation: Cancer deaths continue to decline nih.gov/news-events/news-rel…
Casey Cosgrove retweeted
The annual report to the Nation on Cancer @AmericanCancer -> continued decline even during #covid period.
acsjournals.onlinelibrary.wi…
Casey Cosgrove retweeted
On behalf of the @OSUCCC_James, I welcome Dr. @KimrynRathmell to @OhioState. I look forward to working together to make The James an even more incredible place for oncology professionals to provide world-class care for our wonderful patients, and to break new ground in research.
I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3
Casey Cosgrove retweeted
I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3
Casey Cosgrove retweeted
Working group report from the 2024 NCI/GCSC endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era academic.oup.com/jnci/articl… #gyncsm #endometrial @CaseCos and others
Casey Cosgrove retweeted
🎤 Check out my interview with Dr. @DaniGlassman, a #GynOncology fellow at @OSUCCC_James
🏅 She is the recipient of the 2025 @GYNCancer FWC #Move4Her Research Grant
🧬 Watch as she talks about her research on #EndometrialCancer with a focus on the high-risk MMR-deficient population
The Foundation for Women’s Cancer and Move4Her are instrumental for providing resources in research critical work that will directly impact patient. Congrats, Dani!
Learn more about the FWC here: foundationforwomenscancer.or…
@FBackesMD @David_Cohn_MD @CaseCos @mollyymorton @LAURAJMOULTON @omalleygynonc @karenluMD @amandanfader @ggardnermd @SGO_org #gyncsm #gyncancer @gynoncjnls @gyncsm @meddles28 @nicoleflemingmd @ShannonWestin @abigailflynt @pedroramirezMD @TeamEndo_MSK #obgynMatch2025
Casey Cosgrove retweeted
Endometrial cancer somatic testing practice patterns among gynecologic oncologists @SGO_org @IGCSociety @ESGO_society @OncoAlert @ASCO sciencedirect.com/science/ar…
Casey Cosgrove retweeted
🚨Hot off the press 🗞️ Check out our article on contemporary practice patterns of somatic testing for endometrial cancer at the link below ⬇️
Thanks @gynoncjnls for publishing our commentary! @CaseCos @OSUCCC_James @SGO_org
sciencedirect.com/science/ar…
Casey Cosgrove retweeted
Adding chemotherapy to radiotherapy was not associated with improved overall survival for patients with intermediate-risk cervical cancer. ja.ma/4kATTzM @nagustiga
Casey Cosgrove retweeted
Intriguing data for neoadjuvant #immunotherapy in resectable MMRd #endometrialcancer - high pathologic response rate but be careful of small n!!!
Looking forward to C93 (pembrolizumab) and Domenica (dostarlimab) study results in advanced and recurrent disease
#SGOMtg #gyncam
Casey Cosgrove retweeted
Phase II study by Dr Lee using induction Nivolumab in surgically resectable MMR-d stage I-III #endometrialcancer showed 80% CR in 15 patients. #SGOMtg #SGO2025
Casey Cosgrove retweeted
This meeting will be 🔥🔥🔥🔥
Wondering which renowned experts will be speaking at the 2025 Annual Meeting on Women's Cancer? Get ready to hear from leaders in the field—we hope you're as excited as we are!
Explore speaker bios:
shorturl.at/GTnPe
#SGOMtg #MultiplyYourImpact
Casey Cosgrove retweeted
Wondering which renowned experts will be speaking at the 2025 Annual Meeting on Women's Cancer? Get ready to hear from leaders in the field—we hope you're as excited as we are!
Explore speaker bios:
shorturl.at/GTnPe
#SGOMtg #MultiplyYourImpact
Casey Cosgrove retweeted
🚴♂️🔥 @Pelotonia 2025 registration is OPEN! Join Team Buckeye – #PIIO in the fight against cancer! 100% of funds go to #cancer_research. Sign up today: pelotonia.org/ → Register → Join “Team Buckeye – Pelotonia Institute for Immuno-Oncology.” Let’s do this! #OneGoal
